What conditions does the DISP1 genetic test help diagnose?

This test identifies pathogenic variants in the DISP1 gene associated with craniofacial anomalies like holoprosencephaly and related neurodevelopmental disorders.

Can this test be done at home?

Yes, we offer VIP Mobile Phlebotomy service for home collection across the UAE between 8 AM and 11 PM. Samples are transported under temperature-controlled conditions.

How long does it take to get the results?

Results are typically delivered within 3 to 4 weeks from the date the sample is received at the laboratory.

What type of sample is needed for this test?

A peripheral whole blood sample is required, typically 2–5 mL collected in an EDTA tube.

Genetics → Single Gene Sequencing

Results: 3–4 Weeks Sample: Peripheral whole blood

Test Price

2,800 AED

✅ Home Collection Available

📋 Results in 3–4 Weeks

DISP1 Gene Craniofacial & Neurodevelopmental Abnormalities Genetic Test | 2800 AED | DHA Licensed, Dubai, UAE

Q: Is this test covered by UAE health insurance?

Many UAE insurance providers cover genetic testing with pre-authorisation. We can verify your coverage via WhatsApp at +971 54 548 8731 and handle direct billing where applicable.

Executive Summary & Core Metrics

Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 accredited next-generation sequencing (NGS) genomic processing for the DISP1 gene.
Logistics & Collection: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM across all UAE emirates.
Post-Test Support: DHA-licensed genetic counsellor provides telephonic result interpretation and clinical guidance within 72 hours of report delivery.
Insurance & Billing: Direct billing verification and pre-authorisation support via WhatsApp at +971 54 548 8731.

Key Clinical Metrics

Test Type: Single-gene sequencing with CNV detection
Platform: Illumina NGS, whole coding region ±20 bp
Turnaround Time: 3–4 weeks from sample receipt
Specimen: Peripheral whole blood (2–5 mL in EDTA tube)
DHA Facility License: 1143, Dubai Healthcare City

Test Overview & Methodology

This state-of-the-art NGS test screens the entire DISP1 gene for pathogenic variants linked to craniofacial malformations (e.g., holoprosencephaly spectrum) and neurodevelopmental delay. The assay detects single nucleotide variants (SNVs), small insertions/deletions (indels), and copy number variants (CNVs) across all coding exons and flanking intronic regions (±20 bp).

Feature	Our Test (NGS)	Closest Alternative (Sanger)
Precision & Coverage	Full coding region ±20 bp; detects SNVs, indels, CNVs	Single exon sequencing; limited variant coverage
Methodology	Next-Generation Sequencing (NGS) on Illumina platform	Capillary electrophoresis (Sanger dideoxy)
Turnaround Time	3–4 Weeks	6–8 Weeks

Physician Insight & Safety Protocols

"Molecular confirmation of DISP1 variants provides a critical diagnostic anchor for families navigating craniofacial and neurodevelopmental presentations. However, these results must always be interpreted alongside a comprehensive clinical evaluation by a paediatric neurologist or clinical geneticist. The test is a powerful tool — not a standalone diagnosis."

— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403

Pre-Test Advisory

Important Clinical Guidance Before Testing

This genetic test is intended for diagnostic confirmation and risk assessment only. It does not replace a full clinical workup, imaging studies, or specialist consultation. Patients and guardians should review all benefits, limitations, and potential implications of genetic testing with a qualified healthcare provider before proceeding. Results may have implications for family members; cascade testing counselling is recommended.

Exclusion Criteria & Emergency Red Flags

Exclusion: Patients unable to provide informed consent. Minors must have documented guardian consent per UAE Federal Decree-Law No. 4 of 2016 on Medical Liability.
Exclusion: Active bleeding disorder not medically cleared for venipuncture; sample collected in non-standard or unlabelled container.
Exclusion: Previous allogeneic bone marrow transplant (may cause donor DNA interference in genetic analysis).
🚨 Red Flag: If the patient experiences acute neurological deterioration (prolonged seizure, loss of consciousness, severe developmental regression) before receiving results, seek emergency medical care immediately.

Patient FAQ & Clinical Guidance

1. What does the DISP1 genetic test detect?

This NGS-based test reads the entire DISP1 gene to identify pathogenic variants that cause craniofacial anomalies such as holoprosencephaly and associated neurodevelopmental disorders. It is the most comprehensive single-gene confirmatory tool currently available in the UAE.

2. How long does the test take and can it be performed at home?

Results are delivered within 3 to 4 weeks after sample receipt. Yes, our hospital-grade VIP Mobile Phlebotomy service sends a certified phlebotomist to your home anywhere in the UAE between 8 AM and 11 PM — no clinic visit required. Samples are transported under temperature-controlled cold-chain logistics.

3. Is this test covered by UAE health insurance?

Many UAE insurance providers cover genetic testing when pre-authorised by a specialist. We verify your coverage via a quick WhatsApp message and handle direct billing where applicable. Contact +971 54 548 8731 for a confirmation within 24 hours.

UAE Regulatory & Data Privacy Adherence

Healthcare Compliance & Data Protection Framework

DNA Labs UAE operates under DHA Facility License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. All genetic testing services comply with:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing the collection, processing, and storage of genetic and health data with explicit patient consent.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — regulating the secure handling of electronic health records and digital clinical data.
Federal Decree-Law No. 4 of 2016 on Medical Liability — ensuring patient safety, informed consent, and clinical accountability throughout the testing pathway.

ISO 9001:2015 certification (certificate no. INT/EGQ/2509DA/3139) underpins our quality management system. All genetic results are released only to the requesting physician or authorised patient portal with multi-factor authentication.

Clinical & Logistical Metadata

Test Name	DISP1 Gene Craniofacial & Neurodevelopmental Abnormalities Genetic Test
Price (AED)	2,800 AED
Turnaround Time	3–4 Weeks
Sample Type / Matrix	Peripheral Whole Blood (2–5 mL in EDTA tube)
Methodology Used	Next-Generation Sequencing (NGS) on Illumina Platform
ICD-10-CM Code	Q04.2, Q87.0, Z15.89
LOINC Code	76679-8
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

💬 التحقق عبر الواتساب Verify via WhatsApp 📞 Call Team

Available in Arabic, English, Hindi & Urdu

Preparation Required

[]

Medically Reviewed by Dr. Lina Osama Zaki Quteineh

All content reviewed by qualified professionals for accuracy.

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians

Related Tests

Single Gene Sequencing

DISP1 Gene Craniofacial & Neurodevelopmental Abnormalities Genetic Test | 2800 AED | DHA Licensed, Dubai, UAE

Executive Summary & Core Metrics

Test Overview & Methodology

Physician Insight & Safety Protocols

Pre-Test Advisory

Important Clinical Guidance Before Testing

Exclusion Criteria & Emergency Red Flags

Patient FAQ & Clinical Guidance

1. What does the DISP1 genetic test detect?

2. How long does the test take and can it be performed at home?

3. Is this test covered by UAE health insurance?

UAE Regulatory & Data Privacy Adherence

Clinical & Logistical Metadata

التحقق من التغطية التأمينية

Preparation Required

Related Tests

Crigler-Najjar Syndrome Single Gene Sequencing Test

AAAS Full Gene Sequence Analysis (Allogrove Syndrome) Test

CYLD Gene Analysis for Spiegler-Brooke Syndrome (NGS) Test

RET Gene (Exons 5, 8, 10, 11, 13–16) Selective Sequencing (NGS) Test

How would you prefer?

DISP1 Gene Craniofacial & Neurodevelopmental Abnormalities Genetic Test | 2800 AED | DHA Licensed, Dubai, UAE

Executive Summary & Core Metrics

Test Overview & Methodology

Physician Insight & Safety Protocols

Pre-Test Advisory

Important Clinical Guidance Before Testing

Exclusion Criteria & Emergency Red Flags

Patient FAQ & Clinical Guidance

1. What does the DISP1 genetic test detect?

2. How long does the test take and can it be performed at home?

3. Is this test covered by UAE health insurance?

UAE Regulatory & Data Privacy Adherence

Clinical & Logistical Metadata

التحقق من التغطية التأمينية

📋 Preparation Required

Related Tests

Crigler-Najjar Syndrome Single Gene Sequencing Test

AAAS Full Gene Sequence Analysis (Allogrove Syndrome) Test

CYLD Gene Analysis for Spiegler-Brooke Syndrome (NGS) Test

RET Gene (Exons 5, 8, 10, 11, 13–16) Selective Sequencing (NGS) Test

Preparation Required